Results 91 to 100 of about 2,095,269 (256)

Effectiveness of Acceptance and Commitment Therapy Management on Self-Differentiation and Fear of Disease Progression in Patients with Breast Cancer

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2020
BACKGROUND AND OBJECTIVE: Fear of disease progression and rejection of what happened and not being able to distinguish oneself from mental processes cause confusion in mental health.
M Hasannezhad Reskati, SH Hosseini, R Alizadeh-Navaei, S Khosravi, B Mirzaian   +4 more
doaj  

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient

Clinical Case Reports, 2019
A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and
Linda Brokāne, Inta Jaunalksne, Andra Tilgase, Evija Olmane, Donatas Petroška, Agnija Rasa, Pēteris Alberts   +6 more
doaj   +1 more source

Progression-free survival curve of the 13 patients.

, 2018
The 5-year progression-free survival rate was 63.5%.
Yifei Wang (95207), Tao Ji (1313499), Wei Guo (86150), Zhongyan Chen (1883233), Ran Wei (295560)   +4 more
core   +1 more source

Developing and validating a predictive model for stroke progression [PDF]

, 2011
<p><b>Background:</b> Progression is believed to be a common and important complication in acute stroke, and has been associated with increased mortality and morbidity.
O. Wu, Gilmour, H., L.E. Craig, Langhorne, P., M. Barber, P. Langhorne, Craig, L.E., H. Gilmour, Barber, M., Wu, Olivia   +9 more
core   +1 more source

From junk to function — How weak selection in eukaryotes builds new parts and drives genomic complexity

FEBS Letters, EarlyView.
How do genomes gain new functional parts? In eukaryotes, which tend to evolve under weak selection, much of the genome is junk. Palazzo and Qiu borrow the logic of Markov chains to show how non‐functional DNA becomes functional through the appearance of intermediate states, which arise due to epistasis, buffering, and biochemical messiness, allowing ...
Alexander F. Palazzo, Yi Qiu
wiley   +1 more source

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

Frontiers in Oncology
IntroductionLimited survival data are available for patients with metastatic non-small cell lung cancer (mNSCLC) who stop immune checkpoint inhibitor therapy (ICI) early for reasons other than progression of disease (POD), such as immune-related adverse ...
Blake J. McKinley, Tanmayi S. Pai, Emily B. Wolf, Shenduo Li, Guilherme Sacchi de Camargo Correia, Yujie Zhao, Rami Manochakian, Yanyan Lou   +7 more
doaj   +1 more source

Progression-free survival according to BMI status at baseline.

, 2018
Progression-free survival according to BMI status at baseline.
Ji Kon Ryu (481706), Jun Hyuk Son (2921766), Woo Hyun Paik (481705), Jae Woo Lee (2072779), Young Hoon Choi (2725033), Sang Hyub Lee (5047862), Yong-Tae Kim (249037), Jinwoo Kang (5047865), Jin Ho Choi (3852334)   +8 more
core   +1 more source

Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes : retrospective analysis of the DCCT study [PDF]

, 2013
Background: To examine the effects of physical activity on the development and progression of microvascular complications in patients with type 1 diabetes. Methods: A retrospective analysis of data from the Diabetes Control and Complications trial was
Krishnarajah Nirantharakumar, Saravanan, Ponnusamy, Narendran, Parth, Caroline BT Makura, Nirantharakumar, Krishnarajah, Narendran, Partheepan; id_orcid, Parth Narendran, Girling, Alan J, Ponnusamy Saravanan, Makura, Caroline BT, Alan J Girling   +10 more
core   +2 more sources

Prospecting the protein design landscape

FEBS Letters, EarlyView.
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona, Katharina T. Stonig, Jens Meiler, Clara T. Schoeder, Monica L. Fernández‐Quintero   +4 more
wiley   +1 more source

Risk factors for scoliosis progression in children with idiopathic short stature on growth hormone therapy

Journal of Orthopaedic Surgery and Research
Objective To analyze the clinical characteristics of scoliosis in children with idiopathic short stature after growth hormone treatment, and to explore the influence of growth hormone treatment on the progression of scoliosis and the risk factors for the
Xinkai Zhang, Haiping Ouyang, Xueben Han, Hailun Yao, Yu Zhou, Xing Liu   +5 more
doaj   +1 more source